: Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’

by | Jul 31, 2022 | Stock Market

and Pfizer
have not yet started clinical trials for the new COVID-19 shots that are expected to better target the BA.4 and BA.5 strains of the virus.  It has long been expected that the COVID-19 vaccines need to be reformulated to better protect against curre …

Article Attribution | Read More at Article Source

Share This